Skip to Main Content

LABD  Direxion Daily S&P Biotech Bear 3X…
Exchange-Traded Fund
NYSE Arca

Morningstar Summary

Ratings & Reports

  • Overall
    as of --
    Star Rating: 0Not Rated
    Out of -- funds
  • 3 Year
    Star Rating: 0Not Rated
    Out of -- funds
  • 5 Year
    Star Rating: 0Not Rated
    Out of -- funds
  • 10 Year
    Star Rating: 0Not Rated
    Out of -- funds

Historical Risk

  • Low
  • Below Average
  • Avg
  • Above Average
  • High

Historical Return

  • Low
  • Below Average
  • Avg
  • Above Average
  • High

Morningstar Style Box

Market Cap vs. Investment Style
Selected Values: Investment Style: Mid, Market Cap: Growth
Value
Blend
Growth
Large
Mid
Small

Price Movement of LABD

Chart for Price Movement
LABD is up 2.25% over the last 3 days.
Bid/Ask1$14.90 / $14.99
Open$14.55
Previous Close$14.68
Day Low/High
Last Price
$14.98  19% or $0.13 from its Day high
$14.39
$15.11
52 Week Range
Last Price
$14.98  1% or $1.64 from its 52 Week low
$13.34
1/13/2017
$103.62
2/09/2016
Price/Earnings--
Price/Cash Flow--
Price/Revenue--

Fund Detail

as of 12/31/2016

Profile

Profile
Total Net Assets$62.6 M
Premium/Discount0.00%
Portfolio Turnover--
Total Holdings12
Fund TypeETF
Transaction FeeYes

Distributions and Yield

Distributions and Yield
Distribution Yield0.00%
Most Recent Dividend--
Previous Pay Date--
Ex-Date--
Distribution FrequencyAnnually
SEC Yield--

Total Returns

as of 12/31/2016

Standardized Returns

Standardized Returns: Monthly
Description3 Month1 Year3 Year5 Year10 YearInception3 Month1 Year3 Year5 Year10 YearInception3 Month1 Year3 Year5 Year10 YearInception
LABD Market Price
-38.47%-77.55%-------45.72%9.73%-39.05%-------38.00%9.73%-39.05%-------38.00%
LABD NAV
-38.63%-77.62%-------45.72%9.60%-39.05%-------37.54%9.60%-39.05%-------37.54%
Trading--Inverse Equity
Morningstar Category
------------0.26%-24.20%-16.81%-30.49%-20.82%--0.85%-14.46%-21.11%-29.79%-20.40%--
S&P 500
Index
6.77%23.51%9.60%14.09%7.04%10.53%3.82%11.96%8.87%14.66%6.95%10.51%3.82%11.96%8.87%14.66%6.95%10.51%
View Performance >

Top 5 Holdings

as of 12/31/2016
Top 5 Holdings
--Fidelity Institutional Go19.97%
--S&P Biotechnology Select8.90%
--Fidelity Institutional Go7.93%
--S&P Biotechnology Select Industry USD7.55%
--S&P Biotechnology Select4.26%
Total
48.61%
More Holdings >

Top Sectors

Sectors data unavailable
Top SectorsTop Sectors
Fund Highlights
Fund Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, creates short positions by investing at least 80% of its assets in: swap agreements; futures contracts; options; reverse repurchase agreements; exchange-traded funds ("ETFs"); and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index. The index includes domestic companies from the biotechnology industry. The fund is non-diversified.
Morningstar Category
These funds seek to generate returns equal to an inverse fixed multiple of short-term returns of an equity index. The compounding of short-term returns results in performance that does not correspond to those of investing in the index with external leverage. For example, a fund attempting to achieve negative 2 times the returns of a given index on a daily basis is unlikely to deliver anything like negative 2 times the index's returns over periods longer than one day. Many of these funds seek to generate a multiple typically negative 1 to negative 3 times the daily or weekly return of the reference index. Trading funds are not considered suitable for a long-term investor and are designed to be used by active traders.
  • Inception Date
    05/28/2015
  • 0.96%
    Net Expense may include reimbursements or fee waivers, which may be voluntary or contractual and may expire. See prospectus for more details.
  • Gross Expense Ratio
    1.55%
  • Index Fund
    Yes
  • Leveraged Fund
    Yes
  • Socially Conscious
    No
  • Actively Managed
    No
  • Fund Family
Opens a modal dialogOpens a modal dialogOpen flyout contentOpens a new window